drugset
drugset / Trial / NCT04089176

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

NCT04089176 ↗

Phase 0 Completed 120 enrolled Department of Medical Services Ministry of Public Health of Thailand
RandomizedParallel-groupDouble-blindTreatment

Summary

Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section

Timeline

Start
2019-02-01
Primary completion
2019-04-30
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intravenous
Comparator Oxytocin Peptide 20 iu Intravenous

Indications

No indication recorded.